TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 19, No. 17 September 3, 2013
__________________________________________________________
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
UPCOMING MEETINGS & EVENTS
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 19, No. 17 September 3, 2013
(The next issue will be on September 16, 2013)
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None Submitted for this issue.
__________________________________________________________None Submitted for this issue.
UPCOMING MEETINGS & EVENTS
General info on upcoming meetings of interest:
http://tf7.org/meetings.htm
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
ISTH also maintains a list of upcoming meetings of
interest:
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
Amarnath A, Lenin V, Archunan G (2013) Evaluation of the
hypolipidemic activity of 6,7-dimethoxycoumarin on placental tissue factor mRNA
expression in experimental anti-phospholipid syndrome.
Pharmacogn Mag 9:264-270.
Bolton SA, Sutton JC, Anumula R, Bisacchi GS, Jacobson B,
Slusarchyk WA, . . . Seiler SM (2013) Discovery of nonbenzamidine factor VIIa
inhibitors using a biaryl acid scaffold. Bioorg Med Chem Lett.
Brenden N, Madeyski-Bengtson K, Martinsson K, Svard R,
Albery-Larsdotter S, Granath B, . . . Lovgren A (2013) A triple-transgenic
immunotolerant mouse model. J Pharm Sci 102:1116-1124.
Collier ME, Mah PM, Xiao Y, Maraveyas A, Ettelaie C
(2013) Microparticle-associated tissue factor is recycled by endothelial cells
resulting in enhanced surface tissue factor activity. Thromb Haemost 110.
Demissie A, Shahani L, Khan A, Desai M (2013) Acquired
haemophilia A initially diagnosed as angioedema. BMJ Case Rep 2013.
Duga S, Salomon O (2013) Congenital Factor XI Deficiency:
An Update.
Semin Thromb Hemost.
Erkan D, Willis R, Murthy VL, Basra G, Vega J, Ruiz-Limon
P, . . .
Pierangeli SS (2013) A prospective open-label pilot study
of fluvastatin on proinflammatory and prothrombotic biomarkers in
antiphospholipid antibody positive patients. Ann Rheum Dis.
Etscheid M, Muhl L, Pons D, Jukema JW, Konig H, Kanse SM
(2012) The Marburg I polymorphism of factor VII activating protease is
associated with low proteolytic and low pro-coagulant activity.
Thromb Res 130:935-941.
Ghosh M, Ahmad S, Jian A, Li B, Smith RW, Helm KM, . . .
Reynolds SD
(2013) Human Tracheobronchial Basal Cells: Normal Versus
Remodeling/Repairing Phenotypes in vivo and in vitro. Am J Respir Cell Mol
Biol.
Gissel M, Orfeo T, Foley JH, Butenas S (2012) Effect of
BAX499 aptamer on tissue factor pathway inhibitor function and thrombin
generation in models of hemophilia. Thromb Res 130:948-955.
Gruber SN, Volles DF (2013) Usefulness of laboratory
values in predicting effectiveness of recombinant factor VIIa in surgical
patients with bleeding. Am J Health Syst Pharm 70:1528-1532.
Haffner E, Pietsch U, Fosel T, Lindemann W (2013)
[Treatment of a pregnant patient after multiple trauma: rare combination with
thrombotic thrombocytopenic purpura]. Anaesthesist 62:125-129.
Hemmeryckx B, Hoylaerts MF, Deloose E, Van Hove CE,
Fransen P, Bult H, Lijnen HR (2013) Age-associated pro-inflammatory adaptations
of the mouse thoracic aorta. Thromb Haemost 110.
Henn LW, Esmailian F (2013) Repair of a Large Main
Pulmonary Artery Aneurysm in a 71-Year-Old Jehovah's Witness Patient. Tex Heart
Inst J 40:350-352.
Hewing B, Parathath S, Mai CK, Fiel MI, Guo L, Fisher EA
(2013) Rapid regression of atherosclerosis with MTP inhibitor treatment.
Atherosclerosis 227:125-129.
Hoffman M, Monroe DM (2012) The multiple roles of tissue
factor in wound healing. Front Biosci (Schol Ed) 4:713-721.
Hvas CL, Fenger-Eriksen C, Hoyer S, Sorensen B, Tonnesen
E (2013) Hypercoagulation following brain death cannot be reversed by the
neutralization of systemic tissue factor. Thromb Res.
Krudysz-Amblo J, Jennings ME, 2nd, Knight T, Matthews DE,
Mann KG, Butenas S (2013) Disulfide reduction abolishes tissue factor cofactor
function. Biochim Biophys Acta 1830:3489-3496.
Lagneaux L, Philippart P, Meuleman N, Stamatopoulos B,
Najar M, Pieters K, . . . Bron D (2013) In vivo production of mesenchymal
stromal cells after injection of autologous platelet-rich plasma activated by
recombinant human soluble tissue factor in the bone marrow of healthy
volunteers. Tissue Eng Part A.
Lavergne M, Jourdan ML, Blechet C, Guyetant S, Pape AL,
Heuze-Vourc'h N, . . . Reverdiau P (2013) Beneficial role of overexpression of
TFPI-2 on tumour progression in human small cell lung
cancer. FEBS Open Bio 3:291-301.
Lester PA, Diaz JA, Shuster KA, Henke PK, Wakefield TW,
Myers DD
(2012) Inflammation and thrombosis: new insights. Front
Biosci (Schol
Ed) 4:620-638.
Long M, Wagner D, Maslach-Hubbard A, Pasko D, Baldridge
P, Annich G
(2013) Safety and efficacy of recombinant activated
factor VII for refractory hemorrhage in pediatric patients on extracorporeal
membrane oxygenation: a single center review. Perfusion.
Lopez-Vilchez I, Galan AM, Hernandez MR, Caballo C, Roque
M, Diaz-Ricart M, . . . Escolar G (2012) Platelet-associated tissue factor
enhances platelet reactivity and thrombin generation in experimental studies in
vitro. Thromb Res 130:e294-300.
Margaritis P (2012) Gene-based continuous expression of
FVIIa for the treatment of hemophilia. Front Biosci (Schol Ed) 4:287-299.
Martin AC, Le Bonniec B, Fischer AM, Marchand-Leroux C,
Gaussem P, Samama CM, Godier A (2013) Evaluation of recombinant activated
factor VII, prothrombin complex concentrate, and fibrinogen concentrate to
reverse apixaban in a rabbit model of bleeding and thrombosis. Int J Cardiol.
Otsuka T (2013) [Mechanism and risk factors of
cardiogenic thromboembolism in patients with atrial fibrillation]. Nihon Rinsho
71:36-40.
Pabinger I, Thaler J, Ay C (2013) Biomarkers for
prediction of venous thromboembolism in cancer. Blood.
Palkovits J, Novacek G, Kollars M, Hron G, Osterode W,
Quehenberger P, . . . Weltermann A (2013) Tissue factor exposing microparticles
in inflammatory bowel disease. J Crohns Colitis 7:222-229.
Palsson R, Vidarsson B, Gudmundsdottir BR, Larsen OH,
Ingerslev J, Sorensen B, Onundarson PT (2013) Complementary effect of
fibrinogen and rFVIIa on clotting ex vivo in Bernard-Soulier syndrome and
combined use during three deliveries. Platelets.
Rayner BS, Figtree GA, Sabaretnam T, Shang P, Mazhar J,
Weaver JC, .
. . Bhindi R (2013) Selective inhibition of the master
regulator transcription factor egr-1 with catalytic oligonucleotides reduces
myocardial injury and improves left ventricular systolic function in a
preclinical model of myocardial infarction. J Am Heart Assoc 2:e000023.
Ruiz-Saez A (2013) Occurrence of Thrombosis in Rare
Bleeding Disorders. Semin Thromb Hemost.
Tardy-Poncet B, Piot M, Brunet D, Chapelle C, Bonardel M,
Mismetti P, . . . Tardy B (2012) TFPI resistance related to inherited or
acquired protein S deficiency. Thromb Res 130:925-928.
Teitel JM, Sholzberg M (2013) Current status and future
prospects for the prophylactic management of hemophilia patients with inhibitor
antibodies. Blood Rev 27:103-109.
Thaler J, Ay C, Mackman N, Metz-Schimmerl S, Stift J,
Kaider A, . . .
Pabinger I (2013) Microparticle-associated tissue factor
activity in patients with pancreatic cancer: correlation with
clinicopathological features. Eur J Clin Invest 43:277-285.
Voils SA, Baird B (2012) Systematic review: 3-factor
versus 4-factor prothrombin complex concentrate for warfarin reversal: does it
matter? Thromb Res 130:833-840.
Young G, Auerswald G, Jimenez-Yuste V, Lambert T, Morfini
M, Santagostino E, Blanchette V (2012) PRO-PACT: retrospective observational
study on the prophylactic use of recombinant factor VIIa in hemophilia patients
with inhibitors. Thromb Res 130:864-870.
Zentai C, Grottke O, Spahn DR, Rossaint R (2013)
Nonsurgical techniques to control massive bleeding. Anesthesiol Clin 31:41-53.
http://www.ncbi.nlm.nih.gov/pubmed/23351533
__________________________________________________________
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
No comments:
Post a Comment